Press Release European Commission Approves Pfizer’s VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis 19 February 2024
Press Release Global Maritime Analytics Market Analysis Report 2024-2028: The Rising Popularity of Marine Tourism – ResearchAndMarkets.com 19 February 2024
Press Release Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer 19 February 2024
Press Release TAGRISSO® (osimertinib) demonstrated overwhelming efficacy benefit for patients with unresectable, Stage III EGFR-mutated lung cancer in LAURA Phase III trial 19 February 2024
Press Release Pulsate Raises $7.75M in Series A Funding Backed By TruStage Ventures and Curql 19 February 2024
Press Release Pulsate Raises $7.75M in Series A Funding Backed By TruStage Ventures and Curql 19 February 2024
